ECC,Eagle Point Credit Company Inc. | Financials

Financials

ECC

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Eagle Point Credit Company Inc.ECC

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Eagle Point Credit Company Inc. is a closed ended fund launched and managed by Eagle Point Credit Management LLC.

It invests in fixed income markets of the United States. The fund invests equity and junior debt tranches of collateralized loan obligations consisting primarily of below investment grade U.S. senior secured loans.

Eagle Point Credit Company Inc. was formed on March 24, 2014 and is domiciled in the United States.

Latest News >

What's Going On With IM Cannabis Stock?

May 1, 2024

IM Cannabis Corp. ( IMCC ) shares are trading higher Wednesday, and the stock is up more than 100% over the past five days. Here's a look at what's going on. The Details: Cannabis stocks soared Tuesday following reports that the DEA will move to reschedule marijuana from a Schedule I to a Schedule III substance. IM Cannabis ( IMCC...

Starbucks Q2 Performance Falls Below Expectations, Morgan Stanley Says

May 1, 2024

12:07 PM EDT, 05/01/2024 (MT Newswires) -- Starbucks' ( SBUX ) fiscal Q2 performance was worse than anticipated, marking a historically weak quarter, Morgan Stanley said in a report Wednesday. The forecast for the fiscal year has been reduced, shifting expectations for growth to the next year, Morgan Stanley said, adding that [t]he worst may be in, and numerous plans...

Johnson Controls Dips Over 6% After Q2 Earnings - Here's Why

May 1, 2024

Johnson Controls International Plc ( JCI ) shares are trading lower on Wednesday. The company reported second-quarter adjusted earnings per share of 78 cents, beating the street view of 75 cents. Quarterly sales of $6.699 billion missed the street view of $6.72 billion. Reported sales in the quarter under review were flat versus prior year and increased 1% organically. The company recorded a pre-tax charge of $750...

What's Going On With CytomX Stock?

May 1, 2024

CytomX Therapeutics, Inc. ( CTMX ) shares are racing higher Wednesday. The company said it will report first-quarter results and provide an initial CX-904 Phase 1a dose escalation update on May 8 after the close of markets. What To Know: CytomX and Amgen, Inc. ( AMGN ) are developing CX-904, a T-cell-engaging bispecific Probody candidate against the epidermal growth factor...